Catyalyst Pharma (CPRX) Surges on Dramatic Analyst Upgrade

October 5, 2016 9:44 AM EDT

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Catyalyst Pharma (NASDAQ: CPRX) is surging in early trade following this morning's 'hot' upgrade from Piper Jaffray, which set a $4 price target on the $1 stock. Shares last traded up 26.8% on volume that is running 71x normal.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Momentum Movers, Trader Talk

Related Entities

Piper Jaffray

Add Your Comment